IL6 and coronary artery disorder: Moreover, a cross-sectional study of 992 individuals with stable coronary artery disease found that RBC DHA+EPA levels were inversely and independently correlated with CRP and IL-6 levels [138], and a randomized controlled study found that chronic (91 d) DHA treatment significantly reduced CRP and IL-6 levels in hypertriglyceridemic men [139].